$44.25
0.78% day before yesterday
Nasdaq, Dec 27, 10:00 pm CET
ISIN
US74838J1016
Symbol
QDEL

Quidel Corporation Stock price

$44.25
+3.13 7.61% 1M
+10.72 31.97% 6M
-29.45 39.96% YTD
-31.19 41.34% 1Y
-87.69 66.46% 3Y
-30.02 40.42% 5Y
+16.17 57.59% 10Y
Nasdaq, Closing price Fri, Dec 27 2024
-0.35 0.78%
ISIN
US74838J1016
Symbol
QDEL
Sector

Key metrics

Market capitalization $2.98b
Enterprise Value $5.59b
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 1.99
P/S ratio (TTM) P/S ratio 1.06
P/B ratio (TTM) P/B ratio 0.93
Revenue growth (TTM) Revenue growth -9.66%
Revenue (TTM) Revenue $2.81b
EBIT (operating result TTM) EBIT $99.40m
Free Cash Flow (TTM) Free Cash Flow $-96.80m
Cash position $143.70m
EPS (TTM) EPS $-27.89
P/E forward negative
P/S forward 1.07
EV/Sales forward 2.01
Short interest 8.51%
Show more

Is Quidel Corporation a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,886 stocks worldwide.

Quidel Corporation Stock Analysis

Unlock Scores for Free

Analyst Opinions

10 Analysts have issued a Quidel Corporation forecast:

6x Buy
60%
3x Hold
30%
1x Sell
10%

Analyst Opinions

10 Analysts have issued a Quidel Corporation forecast:

Buy
60%
Hold
30%
Sell
10%

Financial data from Quidel Corporation

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
2,814 2,814
10% 10%
100%
- Direct Costs 1,683 1,683
5% 5%
60%
1,131 1,131
16% 16%
40%
- Selling and Administrative Expenses 341 341
3% 3%
12%
- Research and Development Expense 231 231
8% 8%
8%
559 559
25% 25%
20%
- Depreciation and Amortization 460 460
0% 0%
16%
EBIT (Operating Income) EBIT 99 99
65% 65%
4%
Net Profit -1,867 -1,867
14,241% 14,241%
-66%

In millions USD.

Don't miss a Thing! We will send you all news about Quidel Corporation directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Quidel Corporation Stock News

Neutral
Business Wire
19 days ago
SAN DIEGO--(BUSINESS WIRE)--QuidelOrtho Corporation (Nasdaq: QDEL) (the “Company” or “QuidelOrtho”), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs and transfusion medicine, today announced the appointments of John R. Chiminski and R. Scott Huennekens to its board of directors (the “Board”), effective December 6, 2024. These a...
Neutral
Business Wire
about one month ago
SAN DIEGO--(BUSINESS WIRE)--QuidelOrtho Corporation (Nasdaq: QDEL) (the “Company” or “QuidelOrtho”), a global provider of innovative in vitro diagnostics technologies designed for point-of-care settings, clinical labs and transfusion medicine, announced today the pricing of the previously announced underwritten secondary offering (the “Offering”) by Carlyle Partners VI Cayman Holdings, L.P. (th...
Neutral
Business Wire
about one month ago
SAN DIEGO--(BUSINESS WIRE)--QuidelOrtho Corporation (Nasdaq: QDEL) (the “Company” or “QuidelOrtho”), a global provider of innovative in vitro diagnostics technologies designed for point-of-care settings, clinical labs and transfusion medicine, announced today the launch of an underwritten secondary offering (the “Offering”) by Carlyle Partners VI Cayman Holdings, L.P. (the “Selling Stockholder”...
More Quidel Corporation News

Company Profile

Quidel Corp. engages in the development, manufacture and market of rapid diagnostic testing solutions. Its portfolio includes rapid immunoassays, cardiac immunoassays, specialized diagnostic solutions and molecular diagnostic solutions. The products are directly sold to end users and distributors and for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies and wellness screening centers. The company was founded in 1979 and is headquartered in San Diego, CA.

Head office United States
CEO Brian Blaser
Employees 7,100
Founded 2022
Website www.quidelortho.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today